Grant Funding Opportunities: 9/20/2013
Weekly Grant Funding Opportunities
Please feel free to send special funding search requests any time (susan_craft@ncbiotech.org). Please note that beginning July 1, 2013, grant funding requests will be rolled into our regular research and will include a fee of $100/hour. Also, let us know if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails. We would love to hear of their successes!
Visit NCBiotech’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips.
Announcements
AUTM is seeking academic and research institution-affiliated startup companies to participate in the AUTM 2014 Venture Forum Business Plan Competition, taking place February 21 during the AUTM Annual Meeting in San Francisco. The first place startup company will receive a $10,000 cash prize sponsored by Hopes Creek Consulting. Applications are due Monday, September 30, 2013. To learn more or register, click here.
Grant Opportunities
Deadline: 10/4/2013
Agency: National Institutes of Health
Program: NIH Transformative Research Awards (R01)
Description: The NIH Transformative Research Awards complements NIH’s traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
Award Amount: Varies
Website: www.grants.gov/web/grants/view-opportunity.html?oppId=238504
Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others.
Deadline: 10/9/2013
Agency: American Brain Tumor Association
Program: Discovery Grant Program
Description: Discovery Grants are one-year, $50,000 grants for high-risk, high-impact projects deemed to have the potential to change current diagnostic or treatment paradigms for adult and pediatric brain tumor care. Investigators from sciences outside traditional biology fields encouraged to apply. Basic molecular biology studies and translational projects are excluded from eligibility for this award. Concepts must focus on new, novel diagnostic or therapeutic approaches.
Award Amount: $50,000
Website: http://hope.abta.org/site/DocServer/2014DGLOIAnnouncementFAQCombo.pdf?docID=10941
Eligibility: Advanced post-doctoral trainees (minimum of three years post-doctorate), junior faculty and principal investigators who have not received funding at the equivalent of an NIH R01 or higher level. Investigators from sciences outside traditional tumor biology fields are encouraged to apply.
Deadline: 10/10/2013
Agency: National Institutes of Health
Program: Instrument Development for Biomedical Applications (R21)
Description: The National Institute of General Medical Sciences (NIGMS) encourages innovative applications for the development of new or improved instrumentation for biomedical research. Projects should propose tools that can be used by a wide range of biomedical or clinical researchers, and not limited to a specific organ or disease.
Award Amount: $175,000.00
Website: http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-14-014.html
Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others
Deadline: 10/15/2013
Agency: Bonnie J. Addario Lung Cancer Foundation
Program: Personalized Oncology for Lung Cancer Patients
Description: Personalized means relating to the specific biology of the individual patient. This could include searching through any of the “-omics” (genomics, proteomics, metabolic, etc.) for relevant markers or patterns of markers of specific and individual types of disease. Oncology in this context means any therapy, which is correlated to relevant biologic markers and targeted to the individual’s specific disease. Early as possible in this context means any protocol, test, or other non-invasive method for identifying Lung Cancer disease as early in the disease as possible. At this time, most of our grants are designed to be “seed” funds for initiating innovative research work. We are looking at projects that have a stated direct and fairly immediate benefit for patients.
Award Amount: $50,000
Website: www.lungcancerfoundation.org/forum/discussion/27/clinical-research-apply-for-funding#Item_1
Eligibility: Individual with doctoral degree doing active research work in lung cancer
Deadline: 10/17/2013
Agency: Dept. of the Army -- USAMRAA
Program: DoD DMRDP Military Infectious Diseases Clinical Trial Award
Description: The FY14 DMRDP MID-CTA is intended to support early phase clinical trials/ testing with the potential to have a major impact on treatment of combat-related or trauma-induced wound infections. These studies must be responsive to the health care needs of military Service Members and Veterans; however, the use of military populations in the clinical trial/ testing is not a requirement. Proposed projects should be designed to demonstrate the safety and efficacy of novel therapies and diagnostics in human patients suffering from serious, debilitating combat-related or trauma-related wound infections. The purpose of such demonstrations is to accelerate translation of greater medical capabilities to patients; this can range from proof of concept (i.e., first in human or Phase 0) trials through Phase II clinical trials, as well as Class I, II, or III medical device trials/testing.
Award Amount: Varies
Website: http://www.grants.gov/web/grants/view-opportunity.html?oppId=235939
Eligibility: Unrestricted